KeyCorp upgraded shares of LifeStance Health Group (NASDAQ:LFST - Free Report) to a strong-buy rating in a report released on Monday, April 7th,Zacks.com reports.
LFST has been the topic of a number of other reports. William Blair reaffirmed an "outperform" rating on shares of LifeStance Health Group in a research note on Friday, February 28th. Canaccord Genuity Group assumed coverage on LifeStance Health Group in a research report on Thursday, April 3rd. They issued a "buy" rating and a $8.00 price objective for the company. Finally, The Goldman Sachs Group raised LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $10.00 price target on the stock in a research note on Monday, December 16th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $8.58.
View Our Latest Report on LFST
LifeStance Health Group Price Performance
Shares of NASDAQ:LFST traded down $0.02 during midday trading on Monday, hitting $6.82. The company had a trading volume of 274,604 shares, compared to its average volume of 1,606,736. LifeStance Health Group has a twelve month low of $4.64 and a twelve month high of $8.61. The stock has a market cap of $2.62 billion, a price-to-earnings ratio of -26.23 and a beta of 1.30. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.32 and a quick ratio of 1.32. The business's 50-day simple moving average is $7.28 and its 200-day simple moving average is $7.33.
Insider Activity
In other news, insider Lisa K. Miller sold 18,845 shares of LifeStance Health Group stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $6.90, for a total value of $130,030.50. Following the sale, the insider now owns 339,810 shares of the company's stock, valued at $2,344,689. The trade was a 5.25 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 6.60% of the company's stock.
Institutional Investors Weigh In On LifeStance Health Group
A number of hedge funds and other institutional investors have recently bought and sold shares of LFST. Blue Trust Inc. lifted its position in shares of LifeStance Health Group by 124.4% during the 4th quarter. Blue Trust Inc. now owns 3,828 shares of the company's stock valued at $27,000 after acquiring an additional 2,122 shares during the period. R Squared Ltd acquired a new position in LifeStance Health Group during the fourth quarter worth $80,000. Ameriprise Financial Inc. purchased a new stake in LifeStance Health Group during the fourth quarter worth $87,000. Cibc World Markets Corp acquired a new stake in LifeStance Health Group in the fourth quarter valued at $96,000. Finally, Forum Financial Management LP acquired a new position in shares of LifeStance Health Group during the 4th quarter worth $110,000. Institutional investors and hedge funds own 85.50% of the company's stock.
About LifeStance Health Group
(
Get Free Report)
LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.
Further Reading
Before you consider LifeStance Health Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and LifeStance Health Group wasn't on the list.
While LifeStance Health Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
